Novartis Vaccines: Global Training Management Success
Novartis Vaccines & Diagnostics, a global leader in vaccine production, implemented webTRAINING to manage training across worldwide plants while meeting FDA regulatory standards.
Company Profile
Major Vaccine Producer
Fifth largest influenza vaccine producer globally.
Market Position
Second largest supplier in the USA market.
Regulatory Environment
Subject to strict FDA standards for pharmaceutical production.
Key Challenges
1
User Experience
Functional richness and usability
2
Regulatory Compliance
FDA 21 CFR Part 11 validated system
3
Global Infrastructure
Support thousands of users across continents
Technical Requirements
Training Versatility
Support for online, instructor-led classroom, and on-the-job training formats.
Paperless Operations
Complete elimination of paper-based training materials and records.
Multilingual Support
Multi-language and multi-site capabilities for global deployment.
Integration
Seamless connection with document management systems.
webTRAINING Solution
Document Integration
Procedures automatically create training courses.
Electronic Assessment
Questionnaires attached to each procedure.
Automated Assignment
System identifies who needs training.
Performance Tracking
Real-time KPIs monitor training status.
Gap Management
New Employee Onboarding
Automatic detection of training needs
Role Changes
Training updates when responsibilities shift
Procedure Updates
Retraining when processes change
Scheduled Refreshers
Planned retraining at regular intervals
Key Benefits
Time Savings
Trainers no longer manually examine students or record results.
Self-Service Learning
Employees self-train, self-examine, and monitor progress.
Improved Compliance
Real-time KPIs show training status improvements.
Increased Online Training
Significant growth in online vs. classroom training.
Implementation Results
Plant Adoption
All group plants using webTRAINING at full capacity.
Online Training
Significant increase in online vs. classroom training.
Training Gaps
Considerable reduction in compliance training gaps.